Home > Healthcare > Biotechnology > Bioservices > Optical Genome Mapping (OGM) Market

Optical Genome Mapping (OGM) Market Trends

Report ID: GMI7650
Published Date: Dec 2023
Report Format: PDF

Download Free Sample

Optical Genome Mapping Market Trends

Rising government initiatives and funding play a pivotal role in driving the market size. Government funding facilitates the development of cutting-edge technologies and instrumentation for optical genome mapping. This encourages innovation and contributes to the continuous evolution of optical genome mapping platforms.
Additionally, government-led genomic initiatives such as national precision medicine programs and large-scale genome sequencing projects, create significant demand for advanced genomics technologies like optical genome mapping.

However, the substantial financial investment required for acquiring and maintaining optical genome mapping instruments, along with associated services, poses a challenge for research institutions, laboratories, and healthcare facilities that may hinder the market progress.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

OGM industry size was USD 135.1 million in 2023 and is expected to register 24.1% CAGR from 2024-2032 due to the increasing demand for precision medicine, along with the rising government initiatives & funding worldwide.

The services & software segment held 46.5% share of the OGM industry in 2023 and is expected to register an appreciable CAGR from 2024-2032 as they offer tailored solutions to meet specific research or clinical needs.

North America held 43.3% share of the optical genome mapping industry in 2023 and is expected to register a commendable CAGR from 2024-2032 due to the robust funding mechanisms, including government grants, private investments, and venture capitals in the region.

Bionano Genomics, Inc., Nucleome Informatics Private Limited, Nabsys, Inc., Praxis Genomics LLC, PerkinElmer, Inc., OpGen, Inc., SourceBio International Limited, and MedGenome Labs Private Limited, are some of the major optical genome mapping companies worldwide.